INKT
MiNK Therapeutics (INKT)
$52
About MiNK Therapeutics (INKT)
MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.
Details
Daily high
$0.53
Daily low
$0.48
Price at open
$0.53
52 Week High
$1.90
52 Week Low
$0.46
Market cap
20.7M
Dividend yield
0.00%
Volume
101,497
Avg. volume
54,250
P/E ratio
-1.36
MiNK Therapeutics News
Details
Daily high
$0.53
Daily low
$0.48
Price at open
$0.53
52 Week High
$1.90
52 Week Low
$0.46
Market cap
20.7M
Dividend yield
0.00%
Volume
101,497
Avg. volume
54,250
P/E ratio
-1.36